NASDAQ:KRYS - Krystal Biotech, Inc.
$22.57
 $0.24
+1.07%
4:20PM EDT
2019-02-22
Krystal Biotech, Inc., incorporated on March 31, 2017, gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases. The Companys products include KB103 and KB104. The Companys lead product candidate, KB103, is in preclinical development to treat dystrophic epidermolysis bullosa, or DEB, a rare and severe genetic disease. DEB affects the skin and mucosal tissues, and is caused by one or more mutations in a gene called COL7A1, which is responsible for the formation of protein type VII collagen, or COL7, that forms anchoring fibrils that bind the dermis, or inner layer of the skin, to the epidermis, or outer layer of the skin. KB103 is a replication-defective, non-integrating viralKrystal Biotech, Inc., incorporated on March 31, 2017, gene therapy company. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  KRYS     avg for
industry  
  avg for
sector  
42 stocks weight:  68. 81   0. 00   0. 00  
42 stocks rank:  2. 27 K 2. 00 K 1. 08 K
# analyst opinions:  4. 00   14. 68   14. 18  
mean recommendation:  1. 70   1. 96   1. 94  

quick ratio:  27. 29   5. 17   1. 75  
current ratio:  27. 57   5. 48   2. 10  

target price low:  32. 00   90. 05   118. 16  
target price avg:  42. 25   115. 98   142. 03  
target price high:  53. 00   141. 44   162. 86  
1-yr high:  27. 05   124. 28   143. 16  
last close:  22. 57   102. 75   129. 63  
50-day avg:  23. 14   98. 90   122. 76  
200-day avg:  18. 43   100. 04   123. 17  
1-yr low:  8. 99   78. 22   100. 14  
volume:  23. 63 K 2. 36 M 4. 94 M
50-day avg volume:  40. 48 K 3. 14 M 4. 85 M
200-day avg volume:  58. 34 K 3. 12 M 4. 26 M

1-day return:  1. 07 % 1. 74 % 0. 96 %
this week return:  -1. 83 % -0. 72 % -0. 25 %
12-wk return:  -11. 07 % 1. 23 % -0. 75 %
52-wk return:  147. 59 % -2. 03 % 16. 23 %

enterprise value (EV):  276. 69 M 54. 82 B 107. 48 B
market cap:  325. 64 M 47. 12 B 97. 54 B
EBITDA:  -9. 10 M 4. 72 B 7. 18 B
enterprise multiple (EV/EBITDA):  -30. 40   9. 03   16. 84  
total debt:  0. 00   13. 41 B 16. 70 B
net income (common):  -8. 57 M 2. 34 B 3. 61 B

shares outstanding:  14. 43 M 594. 48 M 1. 22 B
shares:  7. 11 M 592. 96 M 1. 15 B
shares short:  325. 03 K 10. 54 M 11. 92 M
shares short prior month:  245. 69 K 11. 90 M 11. 87 M
short ratio:  7. 52   4. 86   3. 18  
short % of float:  7. 41 % 6. 23 % 2. 78 %
total cash/share:  3. 62   11. 99   10. 04  
total cash:  52. 29 M 7. 30 B 7. 05 B
free cash flow:  -7. 23 M 176. 15 M 2. 43 B
operating cash flow:  -8. 05 M 277. 94 M 3. 06 B

book value:  4. 76   15. 06   28. 80  
price/book:  4. 74   -0. 58   -2. 51  
operating margins:  0. 00 % -466. 96 % -635. 17 %
EBITDA margins:  0. 00 % 13. 54 % 22. 51 %
profit margins:  0. 00 % 6. 67 % 10. 02 %
gross margins:  0. 00 % 48. 21 % 54. 28 %

1-yr max volatility:  23. 92 % --- ---
1-yr mean volatility:  0. 46 % 0. 01 % 0. 07 %

1-yr EPS:  -0. 83   3. 08   4. 11  
forward EPS:  -1. 26   4. 75   7. 18  
P/E:  -27. 32   15. 54   29. 27  
forward P/E:  -17. 72   -20. 90   3. 33  
PE/G:  15. 41   1. 33   6. 07  
growth:  -1. 77 % 755. 42 % 114. 65 %
earnings high:  -0. 20   1. 33   1. 68  
earnings avg:  -0. 23   0. 97   1. 54  
earnings low:  -0. 28   0. 70   1. 41  
revenue high:  -0. 00   2. 81 B 11. 37 B
revenue avg:  -0. 00   2. 70 B 11. 06 B
revenue low:  -0. 00   2. 61 B 10. 84 B
return on assets:  -10. 73 % -3. 63 % 3. 73 %
return on equity:  -16. 73 % 102. 34 % 26. 90 %

beta (1yr vs S&P500):  1. 10   1. 22   0. 94  
sharpe (1yr):  1. 63   0. 14   1. 05  

held % insiders:  33. 63 % 6. 40 % 3. 16 %
held % institutions:  42. 97 % 79. 62 % 70. 81 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-22 : KRYS
.    + 3.925 =         3.925 :: INITIAL WEIGHT
.  + 285.416 =       289.341 :: inverse volume-to-price addition
.  + 518.417 =       807.758 :: spline projection addition
.  - 136.524 =       671.235 :: poor performance penalty
.    x 2.603 =      1747.378 :: one-year gains+dividend factor
.    x 1.004 =      1754.289 :: 13 weeks' performance factor
.    x 1.478 =      2592.741 :: industry recommendation factor
.    x 2.442 =      6330.417 :: symbol recommendation factor
.    x 0.999 =      6323.625 :: return on assets factor
.    x 0.998 =      6313.045 :: return on equity factor
.     x 4.77 =      30113.97 :: current ratio factor
.    x 1.019 =     30681.288 :: quick ratio factor
.    x 1.064 =     32657.615 :: short ratio factor
.    x 2.047 =     66862.747 :: price-to-book factor
.     x 1.23 =     82218.182 :: 5-day avg > 200-day avg
.    x 1.256 =    103231.468 :: 50-day avg > 200-day avg
.    x 1.021 =    105377.032 :: P/E weight
.    x 0.505 =     53181.524 :: PE/G factor
.    x 1.804 =      95944.86 :: beta factor
.    x 1.628 =    156221.206 :: sharpe factor
.    x 1.688 =    263653.343 :: target low factor
.    x 1.311 =    345718.499 :: target mean factor
.    x 1.116 =    385861.313 :: target high factor
.    x 1.012 =    390612.024 :: industry 12-weeks return
.     x 0.99 =     386581.97 :: "drift" penalty 1 days ago
.    x 0.999 =    386353.242 :: overall "drift" factor
.    x 0.761 =    293953.998 :: largest single-day jump factor
.     x 1.01 =    296880.128 :: mean volatility factor
.    x 1.098 =    325841.939 :: 42-day mean volatility factor
.      x 1.0 =     325808.17 :: factor hist industry gain for week 07
.   cubeRoot =         68.81 :: reduced for readability
.                      68.81 :: FINAL WEIGHT for NASDAQ:KRYS


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org